JP2012100676A5 - - Google Patents

Download PDF

Info

Publication number
JP2012100676A5
JP2012100676A5 JP2011290448A JP2011290448A JP2012100676A5 JP 2012100676 A5 JP2012100676 A5 JP 2012100676A5 JP 2011290448 A JP2011290448 A JP 2011290448A JP 2011290448 A JP2011290448 A JP 2011290448A JP 2012100676 A5 JP2012100676 A5 JP 2012100676A5
Authority
JP
Japan
Prior art keywords
antibody
cell
kit
endosialin
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011290448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012100676A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012100676A publication Critical patent/JP2012100676A/ja
Publication of JP2012100676A5 publication Critical patent/JP2012100676A5/ja
Pending legal-status Critical Current

Links

JP2011290448A 2005-04-22 2011-12-29 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体 Pending JP2012100676A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67434405P 2005-04-22 2005-04-22
US60/674,344 2005-04-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008508001A Division JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Publications (2)

Publication Number Publication Date
JP2012100676A JP2012100676A (ja) 2012-05-31
JP2012100676A5 true JP2012100676A5 (https=) 2013-04-04

Family

ID=37215438

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008508001A Pending JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体
JP2011290448A Pending JP2012100676A (ja) 2005-04-22 2011-12-29 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008508001A Pending JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Country Status (6)

Country Link
US (3) US7615372B2 (https=)
EP (1) EP1871809A2 (https=)
JP (2) JP2008538700A (https=)
AU (1) AU2006241235B2 (https=)
CA (1) CA2607455A1 (https=)
WO (1) WO2006116451A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004261229A1 (en) * 2003-07-29 2005-02-10 Eisai, Inc. Antibodies and methods for generating genetically altered antibodies with enhanced effector function
AU2005311660B2 (en) * 2004-12-03 2011-07-07 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
JP2008538700A (ja) 2005-04-22 2008-11-06 モルフォテック、インク. 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体
SI2137217T1 (sl) * 2007-04-05 2014-07-31 Morphotek, Inc. Postopki za inhibiranje vezave endosialina na ligande
WO2010037124A1 (en) * 2008-09-29 2010-04-01 The Trustees Of The University Of Pennsylvania Tumor vascular marker-targeted vaccines
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
US20130305396A1 (en) 2010-09-29 2013-11-14 Luigi Grasso Engineered human endosialin-expressing rodents
NL2007179C2 (en) 2011-07-26 2013-01-29 Stichting Katholieke Universiteit Chitosan-based hydrogels containing enzyme alkaline phosphatase.
WO2014164544A1 (en) 2013-03-09 2014-10-09 Baylor College Of Medicine Vascular-targeted t-cell therapy
GB201702926D0 (en) * 2017-02-23 2017-04-12 Univ Birmingham Modulators
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5789650A (en) * 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
JP4122050B2 (ja) * 1993-02-05 2008-07-23 イージェニックス,インク. ヒト癌腫抗原(hca)、hca抗体、hca免疫アッセイ法、画像化の方法及び治療
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
AU688880B2 (en) * 1994-03-08 1998-03-19 Ludwig Institute For Cancer Research Recombinant humanized anti-FB5 antibodies
DE19541844C1 (de) * 1995-11-09 1997-07-24 Gsf Forschungszentrum Umwelt Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
WO2000013575A1 (en) 1998-09-09 2000-03-16 U.S. Army Institute Of Surgical Research Method for monitoring arterial oxygen saturation
AU2001248352A1 (en) * 2000-03-15 2001-09-24 Epigenomics Ag Diagnosis of diseases associated with the cell cycle
CA2416732C (en) 2000-08-02 2016-02-09 Brad St. Croix Endothelial cell expression patterns
ATE501635T1 (de) 2001-01-15 2011-04-15 Morphotek Inc Chemische hemmstoffe des mismatch-repair
US20040043928A1 (en) * 2001-08-02 2004-03-04 Ramesh Kekuda Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20040014058A1 (en) * 2001-10-05 2004-01-22 Alsobrook John P. Novel human proteins, polynucleotides encoding them and methods of using the same
EP2236614A3 (en) * 2002-08-15 2011-01-26 Genzyme Corporation Brain endothelial cell expression patterns
US20040253606A1 (en) * 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
WO2004078942A2 (en) * 2003-03-04 2004-09-16 Kirin Beer Kabushiki Kaisha Endothelial cell specific antibodies and uses thereof
US6905082B1 (en) * 2003-12-05 2005-06-14 Sheng Li Wu Sprayer device having buffering structure
WO2005086713A2 (en) 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
WO2006017759A2 (en) 2004-08-05 2006-02-16 Kirin Brewery Co., Ltd. Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof
WO2006029045A2 (en) 2004-09-03 2006-03-16 Kirin Brewery Co., Ltd. Endothelial cell specific antibodies and uses thereof
JP2008513533A (ja) * 2004-09-23 2008-05-01 ゲルベ Cestイメージング用の造影剤封入システム
AU2005311660B2 (en) 2004-12-03 2011-07-07 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
EP1856278A2 (en) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
JP2008538700A (ja) * 2005-04-22 2008-11-06 モルフォテック、インク. 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US7908090B2 (en) * 2005-11-30 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Signatures for human aging
US20070141066A1 (en) * 2005-12-16 2007-06-21 Genentech, Inc. Method for Diagnosing, Prognosing and Treating Glioma
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
US20090239223A1 (en) * 2006-07-13 2009-09-24 Siemens Healthcare Diagnostics Inc. Prediction of Breast Cancer Response to Taxane-Based Chemotherapy
US20090176656A1 (en) * 2006-07-21 2009-07-09 Halloran Philip F Tissue rejection
ES2421354T3 (es) 2006-08-11 2013-08-30 Johns Hopkins University Secuencias consenso codificantes de cánceres de mama y colorrectales humanos
US20080300170A1 (en) * 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
WO2008063479A2 (en) * 2006-11-17 2008-05-29 Fred Hutchinson Cancer Research Center Pancreatic cancer biomarkers
US20110119776A1 (en) 2007-02-05 2011-05-19 Wong Kwok-Kin Methods of diagnosing and prognosing lung cancer
WO2008101118A2 (en) 2007-02-14 2008-08-21 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates
EP1986010A1 (en) 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for discriminating colorectal adenomas and adenocarcinomas
SI2137217T1 (sl) * 2007-04-05 2014-07-31 Morphotek, Inc. Postopki za inhibiranje vezave endosialina na ligande
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング/マギル ユニバーシティ 腫瘍細胞由来微小胞
EP2245199B1 (en) * 2008-02-01 2013-11-13 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
US20110117551A1 (en) 2008-02-19 2011-05-19 Oncomethylome Sciences Sa Detection and prognosis of lung cancer
US20110117111A1 (en) 2008-03-26 2011-05-19 Johns Hopkins University Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
US20100092470A1 (en) * 2008-09-22 2010-04-15 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
US20110256560A1 (en) 2008-10-20 2011-10-20 University Health Network Methods and compositions for the detection of ovarian cancer
CA2749601C (en) 2009-01-14 2020-07-21 Stephen M. Hewitt Ratio based biomarkers and methods of use thereof
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules

Similar Documents

Publication Publication Date Title
JP2012100675A5 (https=)
JP2012100676A5 (https=)
TWI853077B (zh) 新型抗cd39抗體
US12453770B2 (en) CLEC9A binding agents
US20240392002A1 (en) Anti-ror antibody constructs
US20200197497A1 (en) Peptidic chimeric antigen receptor t cell switches and uses thereof
US20220002418A1 (en) Anti-pd-l1/vegf bifunctional antibody and use thereof
JP2009521206A5 (https=)
US10138297B2 (en) Antibody neutralizers of human granulocyte macrophage colony stimulating factor
ES2688941T3 (es) Antagonistas del receptor 1 del factor de necrosis tumoral para tratar enfermedades respiratorias
JP7800946B2 (ja) 抗tslpナノ抗体およびその使用
RU2451689C2 (ru) Новые антипролиферативные антитела
JP2016509582A5 (https=)
WO2015032906A4 (en) Cd70-binding peptides and method, process and use relating thereto
WO2018050039A1 (zh) 新的抗pd-1纳米抗体及其应用
JP2017526339A5 (https=)
DE102009045006A1 (de) Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen
HRP20170254T1 (hr) Humanizirana i kimerna monoklonska protutijela usmjerena na cd47
JP2010526028A5 (https=)
CN109485729A (zh) Bcma和cd3的结合分子
EP3178847B1 (en) Anti-tnf-alpha fully human monoclonal antibodies with low immunogenicity and application thereof
JP2014524733A5 (https=)
JP2017522861A5 (https=)
DE102011118022A1 (de) Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung
JP2009521956A5 (https=)